| Reagan-Udall Foundation

Read more about COVID Feel Good-An Easy Self-Help Virtual Reality Protocol to Overcome the Psychological Burden of Coronavirus

In anticipation of the 2025 Strategic Agenda, the Reagan-Udall Foundation and the FDA co-hosted a stakeholder meeting where the FDA received input on what the Hub should prioritize. Dr. Flores represented BIO in the October 2024 meeting.

Coverage

Read more about Bio.News: BIO celebrates release of FDA Rare Disease Innovation Hub 2025 strategic plan

Read more about EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL

Read more about NE3107 in Adults With Neurological Symptoms of Long COVID

Read more about Signet Therapeutics

Read more about Elixirgen Therapeutics, Inc.

Read more about Axcynsis Therapeutics Pte Ltd

Read more about Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer

Read more about Efficacy of Baduanjin Exercise in COVID-19 Contraction Patients With Idiopathic Chronic Fatigue

Read more about TREC@TAMU Cancer Prevention Registry and Repository

Subscribe to

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Subscribe for updates from the Reagan-Udall Foundation for the FDA